The latest research on Myriad Genetics trims the modeled fair value only slightly, from US$8.32 to US$8.12 per share, and aligns a new US$7 price target with expectations across the broader ...
UVA Health’s Dr. Li Li weighs in on new research finding that colon cancer is the leading cause of cancer deaths in people under 50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results